Let’s be honest NICM patients should never get a Lifevest


anonymous

Guest
If the statistics are analyzed the benefit of prescribing Lifevest for NICM is next to none. Medicare needs to look at Risk of SCD for these patients. When they do they will see it’s not needed. It’s a costly add on. Acute MI could benefit but NICM is stealing. Medicare and all commercial insurances need to look at the data and update their policies.